|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.2 TWD | 0.00% |
|
+0.33% | +29.18% |
| Mar. 19 | AP Biosciences Inc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | AP Biosciences Inc Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
AP Biosciences Inc reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 32.25 million. Net loss was TWD 339.3 million compared to TWD 288.54 million a year ago.
Basic loss per share from continuing operations was TWD 5.24 compared to TWD 5.48 a year ago. Diluted loss per share from continuing operations was TWD 5.24 compared to TWD 5.48 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.18% | 121M | |
| +8.63% | 115B | |
| +13.17% | 107B | |
| -12.76% | 22.31B | |
| -3.99% | 21.6B | |
| -7.19% | 18.23B | |
| -39.93% | 17.62B | |
| +6.67% | 14.26B | |
| +33.90% | 12.37B | |
| -28.60% | 8.28B |
AP BIOSCIENCES INC 